Make your own free website on Tripod.com

Home

Noticias y Cifras | Si yo tuviera cancer | Franciscano Cura el Cancer | Factores de Transferencia | Factores de Transferencia II | Parasitos y metales | Equinacea | Ajo, Palo de Arco y Noni | GRAVIOLA Anticancer Fruit | Graviola AntiCancer Fruit 2 | Más Sobre el Cancer | Salve su Cuerpo | Alternative Cancer Treatments | La Ley de Hierro del Cáncer | Tratamientos Oficiales | Terapias Alternativas | Quimioterapia?? | Quimioterapia 2 | Quimioterapia 3 | Médicos tercer causa de muerte en EE.UU. | Testimonios | Aviso Legal
Alternativas Contra el Cancer
Quimioterapia 2

Eficacia Real de los Tratamientos Anticancer

En 1999 año murieron en los de España hospitales 371.102 personas. De ellas, 94.566 (el 25,48%) a causa de tumores; es decir, de cáncer. Luego una de cada cuatro personas que muere en un hospital español lo hace de cáncer. Una cifra mareante que, encima, no refleja la realidad porque buena parte de los enfermos terminales de cáncer son enviados a morir a sus casas por los oncólogos "cuando ya no pueden hacer nada por ellos".

En suma, ¿cuántas personas mueren de verdad de cáncer en España si sólo en hospitales fallecen casi cien mil al año? ¿Un 50% más? ¿El doble? No se sabe. Pero eso sí, se ha avanzado muchísimo en la investigación y tratamiento del cáncer....

Actualmente hay tres vías con las que la Medicina convencional afronta el problema del cáncer: la Cirugía, la Quimioterapia y la Radioterapia.

En lo que se refiere a la Cirugía, se explicó la importancia de detectar a tiempo un tumor antes de que se extienda porque si el mismo se extirpa cuando aún está aislado el problema puede atajarse antes de que sea irremediable. Cuando así se hace, cuando se actúa en la fase inicial, el porcentaje de casos en que el tumor desaparece y no vuelve a aparecer es notable.
Agregaré que, según el conocido Manual Merck de Medicina, la cirugía es suficiente en un alto porcentaje de cánceres (en el de pulmón el porcentaje de éxito es muy bajo).

Obviamente, no hay manera de contrastar sus datos. Pero en él se afirma que incluso en casos incipientes, sin metástasis, la cirugía sola no es suficiente entre un 30 y un 63% de los casos de cáncer de pulmón, del 18 al 35% en los cánceres de boca, testículo, riñón, vejiga, colon, mama, útero, próstata, ovarios y laringe, y en el 6% de los casos de cuello uterino.

En lo que se refiere a la Radioterapia, se reconocería durante el cursillo que a pesar de que mueve miles de millones de dólares al año los resultados son más bien escasos. Una información que no me sorprendió en absoluto ya que, según los expertos que previamente había consultado, la Radioterapia es ineficaz en un alto porcentaje de cánceres. Según el propio Manual Merck, la eficacia de esta terapia sola nada más es aceptable en casos de cáncer iniciales de testículos, en la llamada Enfermedad de Hodgkin, en los linfomas no hodgkinianos y en los cánceres de próstata (entre el 67 y el 90% de los mismos).

En cuanto a la Quimioterapia no se dieron datos de su eficacia pero el Manual Merck indica que, por sí sola, tiene un porcentaje de éxito en los casos iniciales de coriocarcinomas (98%), cáncer de testículos -excepto seminomas- (88%), la Enfermedad de Hodking (74%), el Linfoma de Burkitt (44-74%) y el Linfoma linfoblástico (50%).

¿Y el resultado de combinar las tres terapias, es decir, cirugía-radioterapia, cirugía-quimioterapia, radioterapia-quimioterapia y cirugía-radioterapia-quimioterapia? Pues hay que decir que no se logran resultados mucho mejores en la mayor parte de los casos comentados aunque sí ayuda en otros cánceres no mencionados como los de endometrio (62%), estómago (54%), riñón -tumor de Wilms- (80), sarcoma de Ewing (70%) y sistema nervioso central -meduloblastoma- (71-80%).

Ahora bien, estamos hablando de los resultados que se obtienen en las fases iniciales de desarrollo del cáncer. Porque cuando el cáncer se ha desarrollado y extendido la cuestión es muy otra. En tales casos los porcentajes de "curación" (supervivencia de 5 años sin que se manifieste de nuevo el cáncer) son muy bajos. Pero de eso nadie quiere hablar.

Pobres resultados que ha obligado a todas las compañías -así se nos anunció también que lo ha hecho la Bristyol-Myers Squibb- a realizar un cambio fundamental de estrategia y que los esfuerzos se encaminen ahora en buscar moléculas que inhiban la proliferación celular. Es decir, a encontrar inhibidores específicos de los factores de crecimiento, receptores y GTP de la célula. Y crear tantos inhibidores distintos como tumores hay. Una labor, pues, de muchos años aunque en estos momentos se está investigando ya con 400 moléculas concretas. La nueva "Quimioterapia dirigida" pretende crear cuerpos monoclonales para cortocircuitar la transmisión de la información en la célula cancerosa, moléculas inhibidoras que impidan su replicación logrando que entre en apóptosis, es decir, lograr que la célula se autodestruya -se "suicide"- o sea destruida por las células de defensa del organismo.

Existen, en todo caso, otras vías de investigación. Es el caso de la terapia génica cuya idea básica es introducir material genético en las células -se piensa en retrovirus- para modificar sus funciones. También se pretende desarrollar la Inmunoterapia con la idea de introducir genes para potenciar la respuesta del sistema inmune.
Lo único que hoy está en fase III -probándose ya en humanos- son algunos antitumorales siendo uno de los más conocidos el Taxol fabricado por el laboratorio organizador de este cursillo. Los citotóxicos y los citostáticos se prueban hoy en miles de pacientes aunque no son tan específicos como los nuevos fármacos que se pretenden crear, inhibidores de la señal para interrumpir el ciclo celular e impedir la proliferación cancerosa.

Por supuesto, si toda esta investigación dará o no fruto alguno es una incógnita como los propios ponentes del curso reconocieron. Porque muchas veces las sustancias que dan resultado en animales fracasan posteriormente en humanos. Y, en el mejor de los casos, los fármacos que pudieran salir de estas investigaciones no estarían al alcance de los enfermos antes de varios años. Por consiguiente, no son una esperanza siquiera para los enfermos de hoy, sólo para los de mañana.

De hecho, varias compañías como Dendreon, Inspire Pharmaceuticals o Cubist Pharmaceuticals han informado hace poco de fallos o retrasos en los ensayos clínicos de sus medicamentos. Aunque los dos fracasos recientes más notables es precisamente el de dos anticancerosos, uno de ellos relacionado con la Bristol Myers Squibb, algo que los ponentes del cursillo se abstuvieron de mencionar. Hablamos del Erbitux.

Fabricado por ImClone, la Bristol Myers Squibb llegó en septiembre pasado a un acuerdo por el que se comprometió a pagar 2.000 millones de dólares a cambio del 20% de la empresa y de parte de los derechos del fármaco. Sólo que la FDA, tras ser probado en pacientes que sufrían cáncer colorrectal y que no habían respondido a la terapia habitual, lo rechazó a finales de diciembre pasado porque en los ensayos clínicos no pudo determinarse si la respuesta de los participantes se debía al nuevo medicamento o a los tratamientos habituales. Con lo que la Bristol Myers Squibb ha amenazado con romper el pacto firmado con ImClone si no se le permite controlar los próximos ensayos clínicos.

El otro es el SU5416, un medicamento diseñado para frenar la angiogénesis desarrollado por Sugen Inc., empresa comprada en 1999 por 650 millones de dólares por Pharmacia. Pues bien, los ensayos clínicos tuvieron que detenerse en la última fase tras constatarse que no prolongaba la vida de los pacientes más que la quimioterapia habitual. De los 355 participantes evaluados (con cáncer colorrectal en estadios avanzados) se comprobó que el grupo que recibía el SU5416 combinado con quimioterapia respondía exactamente igual que el que recibía el tratamiento normal sin combinar con el nuevo fármaco. El tiempo de supervivencia, como se esperaba, no aumentó hasta un 33%.

En suma, está por ver a dónde nos llevan esas investigaciones.

EFECTOS SECUNDARIOS DE LA RADIOTERAPIA Y LA QUIMIOTERAPIA

No quiero dejar de hablar, en cualquier caso, de los efectos secundarios de la Radioterapia y la Quimioterapia. Estos varían mucho de un paciente a otro pero las náuseas, los vómitos, la fatiga intensa, la caída del cabello y la pérdida de glóbulos en sangre son los más frecuentes. Al menos tres de cada cuatro pacientes padecerá como consecuencia una anemia severa -disminución de los glóbulos rojos- con la consecuente debilidad, somnolencia, dolor de cabeza, fatiga constante, falta de aire y palpitaciones aunque no necesariamente se presentan a la vez todos los síntomas descritos. Hay quien afirma, por cierto, que en estos casos ayuda la eritropoyetina pero una buena parte de los expertos lo duda.

También bajan los glóbulos blancos ya que resulta afectada la médula ósea y disminuyen las plaquetas -trombocitopenia- impidiendo el control por el cuerpo de una posible hemorragia. Es igualmente corriente observar petequias, hemorragias muy pequeñitas (se ven como puntitos rojos), principalmente en el interior de la boca y en las piernas. También es más fácil hacerse moretones.

Ambas terapias provocan además inflamación e, incluso, úlceras en las membranas mucosas así como en la boca y la garganta.

Asimismo, pueden irritar y dañar las venas inutilizándolas temporal o permanentemente. Y provocar una flebitis. Otras veces las venas se vuelven muy frágiles y se rompen fácilmente con lo que el medicamento administrado puede causar, al salirse, quemaduras en los tejidos vecinos.
Cabe añadir que cuando se trata a una embarazada el riesgo de provocar serias malformaciones en el feto -especialmente en el caso de la Quimioterapia- es altísimo; de hecho, lo normal es que nazca muerto.

Y lo más importante: el organismo se intoxica. Muchas veces irremediablemente. Con lo que se da la paradoja de que al enfermo le desaparece su tumor... pero se muere algún tiempo después porque el organismo le falla al estar envenenado. Y, claro está, esa persona no se habrá muerto de cáncer sino de otra cosa. Y si el fallecimiento se produce con suerte cinco años después, ¡se habrán salvado incluso las estadísticas y esa persona podrá hasta figurar entre los enfermos "libres de cáncer" y engordar los porcentajes de buenos resultados!

Aunque lo más sangrante es que tanto la Radioterapia como la Quimioterapia, que se utilizan para combatir el cáncer, pueden a su vez provocar cáncer. Un sarcasmo.

CONCLUSIÓN

Llegados a este punto no puedo dejar de denunciar que el problema del cáncer está siendo manipulado vergonzosamente. Porque en ningún lugar de Occidente se está atendiendo a consideraciones sanitarias sino políticas. Hay una orden no escrita que hace que las autoridades de todo el mundo intenten minimizar el problema ocultando la verdad. Por eso no se hacen estadísticas oficiales y constatables de los índices de supervivencia en los tratamientos convencionales. Los "éxitos" que con la Cirugía, la Quimioterapia y la Radioterapia se supone que se obtienen se reflejan en datos que aportan quienes fabrican los aparatos de radioterapia, los laboratorios que desarrollan los fármacos y, en el mejor de los casos, los oncólogos que practican ambas técnicas terapéuticas. De la credibilidad los fabricantes y laboratorios no hay mucho que explicar porque de vez en cuando la propia FDA norteamericana, harta probablemente de tanta mentira, les tiene que reconvenir a menudo. Los ensayos clínicos no se efectúan en buena parte de los casos a doble ciego y no los controlan equipos independientes. Y los oncólogos no tienen acceso a otros datos para corroborar la eficacia de lo que hacen por lo que, cuando su fracaso es alto, terminan pensando que han tenido la mala suerte de que a ellos les lleguen casos muy difíciles pero como a otros compañeros les va mejor -eso dicen las estadísticas- lo que tienen que hacer es no desesperar.

Sin embargo, los escasísimos datos fiables que existen son tozudos. Según el Instituto Nacional de Estadística muere hoy casi en España el doble de personas por tumores que hace dos décadas. En 1980 fallecieron de cáncer en hospitales (además de los muertos en casa) 58.431 personas, en l985 -cinco años después- 68.779, en 1990 fueron 79.609, en 1995 se llegó a 89.493 y en 1999 a 94.566. Eso supone el 25,48% de todas las muertes habidas en hospitales. Una de cada cuatro personas. Siendo los índices de mortandad más altos en los casos de cánceres de tráquea, bronquios y pulmón -en primer lugar- y los de colon (la mitad de casos que los anteriores). Les siguen a poca distancia los cánceres "mal definidos, secundarios y no especificados" y los de estómago, mama, próstata, hígado, tejido linfático, vejiga y páncreas. Es decir, que el número más alto de fallecimientos se da entre buena parte de quienes padecen los tipos de cáncer que se supone mejor resultado tienen con Quimioterapia y Radioterapia.

¿Alguien lo entiende?

Las autoridades políticas y sanitarias deberían dar una explicación de todo lo aquí expuesto. Pero no lo harán. No tienen más argumentos que la retórica y echar balones fuera alegando que en otros países se hace lo mismo. Como si ello fuese una razón y no una excusa.

No, la verdad es que aquí hay muchísimo dinero en juego. Cientos de miles de millones de euros. Y el control sobre el negocio, férreo. Ello explica que con tan paupérrimos resultados la Radioterapia y la Quimioterapia sean hoy los tratamientos "oficiales" cuando la cirugía no es viable. Y sólo eso explica también que desde las asociaciones de oncólogos y desde el poder se persiga encima como charlatanes y estafadores a quienes pretenden tratar a los enfermos de cáncer de otra manera. "Si nosotros, que somos los que más sabemos en este ámbito, no conseguimos gran cosa, ¿qué van a poder hacer otros?". Y con tal pensamiento exigen que a quienes tratan a los pacientes de otra manera -médicos incluidos- se les persiga legalmente y se les impida ejercer. Conozco varios casos sangrantes en España.

Médicos a los que sus colegios, en nombre de la verdad que detentan, los han inhabilitado profesionalmente o los han llevado a los tribunales para que lo haga el juez.
Hace ahora un año, un conocido oncólogo, harto de que se le murieran los pacientes, decidió abandonar el ejercicio de la Oncología en el hospital de su comunidad autónoma para el que trabajaba a fin de poder aplicar otras terapias que consideraba más eficaces. Y así lo está haciendo hoy en su consulta privada. Porque en los hospitales públicos un oncólogo sólo puede hacer lo que le indican, no puede ejercer su libre albedrío. Y lo más singular es que hablamos de alguien que hace ya más de 25 años introdujo en su comunidad la Medicina Nuclear. Con alta experiencia, pues, en los tratamientos convencionales. Excuso decir que ya entonces le invité a expresar abiertamente en la revista sus impresiones. Su respuesta fue clara: "Mire usted, me encantaría pero tengo tres hijos aún en casa y debo trabajar para vivir. Y sé que si abro la boca me quitan la licencia como médico. A pesar de haber renunciado a mi cargo de responsable de Oncología en el hospital. Lo siento." No insistí. Hace sólo unos días entré de nuevo en contacto con él y me aseguró que sus resultados, hoy, son mucho mejores que antes. Como los de otros médicos que conozco y que trabajan discretamente para no ser perseguidos y denunciados, al igual que Hamer.

Termino. Sé que quienes padecen cáncer o tienen familiares o amigos que lo sufren estarán angustiados. Y sé que muchas personas dirán que no tiene sentido decirle la verdad a la gente cuando ésta es tan dura. Pero me niego a aceptar esa falacia. La gente tiene derecho a saber la verdad, a estar informada y, sobre todo, a poder elegir tratamientos alternativos a los de la Quimioterapia y Radioterapia si lo desea. Porque los hay aunque las autoridades lo nieguen y persigan a quienes los practican.

Entrevista con el Dr. Ralph Moss "CHEMOTHERAPY, LAETRILE, COLEY'S TOXINS, BURZYNSKI, & CANCER POLITICS" por Laura Lee de "Radio Show New York".

For over two decades, Ralph W. Moss Ph.D., has been an outstanding journalist in the field of cancer. From 1974 to 1977, he was science writer (later assistant director of public affairs) at Memorial Sloan-Kettering Cancer Center in New York. Since being fired for "whistle blowing," he has written ten books which have helped define the field of alternative medicine (Cancer Therapy, The Cancer Industry, Questioning Chemotherapy, Herbs Against Cancer, etc.). Many consider him one of the world's leading authorities on alternative and complementary approaches to cancer. Famed physician and author Dr. Julian Whitaker has said that if he had cancer he would turn first to Dr. Moss.


Julian Whitaker, M.D.Renowned physician Julian Whitaker, M.D.wrote about Ralph W. Moss, Ph.D.'s report service in the November 1995 issue of his Health & Healing newsletter:
"You should know that if I were battling cancer -- or any serious disease, for that matter -- I would be in a constant search for effective, non-toxic therapies. One place to begin that search is with Ralph Moss, Ph.D. He is
probably the most knowledgeable writer in the world on alternative therapies for cancer.... If I had cancer, I would start here for more information."

Laura Lee:
The medical establishment keeps telling us that there are only 3 ways to treat cancer--chemotherapy, radiation and surgery. Many people disagree and among them is Dr Ralph Moss, author of a new book, Cancer Therapy. Dr Moss, can we have a bit of background and why you became interested and decided to devote your practice and research to cancer?

Dr.RALPH MOSS:
Twenty years ago I was hired at Memorial Sloane Kettering (MSK) cancer centre in New York as the science writer, later promoted to assistant director of public affairs. Shortly after I went to work there I went to visit an elderly Japanese scientist, Kanematsu Sugiura, who astonished me when he told me he was working on Laetrile (B17), at the time it was the most controversial thing in cancer ..reputed to be a cure for cancer. We in public affairs were giving out statements that Laetrile was worthless, it was quackery, and people should not abandon proven therapies. I was astonished that our most distinguished scientist would be bothering with something like this, and I said why are you doing this if it does not work. He took down lab books and showed me that in fact Laetrile is dramatically effective in stopping the spread of cancer. The animals were genetically programmed to get breast cancer and about 80 - 90% of them normally get spread of the cancer from the breast to the lungs which is a common route in humans, also for how people die of breast cancer, and instead when they gave the animals Laetrile by injection only 10-20% of them got lung metasteses. And these facts were verified by many people, including the pathology department.

Laura Lee: So this is verified, that Laetrile can have this positive effect?

Dr.RALPH MOSS:
We were finding this and yet we in public affairs were told to issue statements to the exact opposite of what we were finding scientifically, and as the years went by I got more rapped up in this thing and 3 years later I said all this in my own press conference, and was fired the next day, "for failing to carry out his most basic job responsibility"--ie to lie to the public what goes on in
cancer research

Laura Lee: How can these people justify this in their own minds?

Dr.RALPH MOSS:
Basically the attitude was best expressed by Lewis Thomas, the president of the centre, who told my boss, as he would not see me, "I am not going to die on the barricades for Laetrile. It is not a cure, it is only a palliative, (meaning it relieves pain and stops the spread of cancer), if it were a cure it might be a different story, but I am not going to give up my career, to die on the barricades". That's how they justified it in their own minds. I could not do that, nor could Dr Sugiura, who never renounced the results of his own studies, despite the fact they put enormous pressure on him to do so.

Laura Lee:
Are we practicing science here, or medicine, or politics?

Dr.RALPH MOSS: Politics. Political science as we say!

Laura Lee:
You were mentioning that patients hear cure rate when something very different is being talked about. And we can go into the poor statistics for the standard modalities. They are not that effective, which is why everyone is looking for an alternative.

Dr.RALPH MOSS:
When I was at MSK a lot of very weird things started to happen to me, there was this cognitive distance between what I was told, and was writing about treatment, especially chemotherapy, and what I was seeing with my own eyes. One time I heard the head of the intensive care unit give a talk in which he bragged about how he had one of the lowest mortality rates in his unit. I went out to lunch with him, where he became a bit inebriated, and told me how he managed to get those statistics---by wheeling the dying patients out into the corridor where they died and didn't sully our departments record.

Laura Lee:
Lets skew those statistics any way that looks good to us.

Dr.RALPH MOSS:
Another time I went to interview a breast surgeon, and he had a lamp in the shape of a women's breast on his desk. I couldn't even get out a single interview question I was so astounded by this insensivity, and here women were flocking in to have their breasts removed by this guy, and I thought...I didn't have any idea what was wrong but it was that twilight zone of knowing, feeling that something was definitely wrong but not knowing what it was. It was only
when I had the enforced leisure from being fired that I was able to really look into it.

Laura Lee:
It is interesting how many establishment doctors start out, in many cases to disprove the efficacy of alternative therapies and become advocates of alternative therapies. I don't hear many stories of the other way round.

Dr.RALPH MOSS:
No, it is not likely. So, I started to look into the whole question of chemotherapy in particular, that is the cutting edge of orthodox treatment and I have now completed a report---Chemotherapy, How, When, and Why. With emphasis on
the why. Although we do give some information for those who are taking chemotherapy on what they can take to decrease the side effects. Basically it is a very critical and comprehensive look, for we deal with about 60 different
types of cancer, and all of the FDA approved anti cancer drugs. The bottom line is for a few kinds of cancer chemo is a life extending procedure---Hodgkin's disease, Acute Lymphocytic Leukemia, Testicular cancer, and Choriocarcinoma. Testicular cancer has yielded to platinum containing drugs.

Laura Lee:
It probably makes you impotent

Dr.RALPH MOSS:
It does more than that. It is extremely damaging to the body, but it does lead to a very extended life for people with this problem. An interesting thing is that platinum is the old homoeopathic drug for problems of the testicles or the ovaries, and Hahnemann proved that on himself 180 years ago, but Allopathic medicine takes this basic idea, without giving credit of course, ups the dose by the billions because they can't conceive of small doses having significant biological effect, and consequently put in massive amounts of homoeopathic medicines and cause tremendous toxicity and other problems, second cancers down
the road and so forth. Outside those 4 or 5 treatments for which chemotherapy is effective there are a few where there is very moderate effectiveness in terms of life extension---lung cancer and ovarian cancer with a possibility of colon
cancer.

Laura Lee:
When you look at the statistics chemotherapy is a standard treatment for all types of cancer generally speaking.

Dr.RALPH MOSS:
Yes, it has become.

Laura Lee:
However, when you really look at the statistics, you were saying, only a few respond.

Dr.RALPH MOSS:
Yes, 2-4%.

Laura Lee:
How in the world, Dr Moss, can it be considered a standard cure, when it works for 2-4, and very specific ones?

Dr.RALPH MOSS:
We are dealing with an industry. It is not supported by the facts. The way that it is done is this. The drugs are tested in test tubes, and they look for things that will kill cells. After you have found something that kills cells, cancer cells, cell lines which are very abnormal non-typical sort of growths, maybe a new life form almost, then you put it into animals. Then if it kills the cancers
before it kills the animals, and shrinks the tumours, you consider you have an active agent. You then put it into people, and go through the 3 phases the FDA prescribes for this, and basically if you can shrink the tumour 50% or more for 28 days you have got the FDA's definition of an active drug. That is called a response rate, so you have a response..


Laura Lee:
Different from a cure?

Dr.RALPH MOSS:
Quite a bit because when you look to see if there is any life prolongation from taking this treatment what you find is all kinds of hocus pocus and song and dance about the disease free survival, and this and that. In the end there is no proof that chemotherapy in the vast majority of cases actually extends life, and this is the GREAT LIE about chemotherapy, that somehow there is a correlation
between shrinking a tumour and extending the life of the patient.

Laura Lee:
Or that there is a correlation between looking at a cancer cell in a test tube and the tumour in someone's body.

Dr.RALPH MOSS:
Absolutely. What happens as you grow those cells in cell lines they become very weird. Hundreds and hundreds of generations later they don't even look like even normal human cancer cells. They are things that grow under glass, immortal cells, unlike normal body cells or normal cancer cells. So much cancer research is very questionable because it is based on this cell line research.

Laura Lee:
Politics it seems is the word you must understand in order to understand what is going on. It is not science, it is not medicine, it is politics..

Dr.RALPH MOSS:
And big money You have to understand that cancer is 1/9th of the overall health budget in the United States. The last figures I have seen from the American Cancer Society of money spent on cancer indirectly or directly at 107 Billion
dollars.

Laura Lee:
AIDS is a 4 billion dollar..

Dr.RALPH MOSS:
Research, but you can't come compare AIDS to cancer. Cancer we are talking about well over a million cases a year, not counting skin cancer which probably equals that.

Laura Lee:
One million new cases discounting skin cancer?

Dr.RALPH MOSS:
Right. About 630,000 people die every year of cancer in the US, and it really is an epidemic disease. We have got a tremendous industry. Every one of those people who is getting cancer and dying of it is going to be treated, and these treatments are extremely expensive. Chemo is tens of thousands, sometimes hundreds of thousands of dollars. A bone marrow transplantation which is basically another way of giving chemotherapy or radiation can run to about
150,000 dollars per person, and is almost never effective. It kills about 25%..

Laura Lee:
Why carry on doing it?

Dr.RALPH MOSS:
Because of the money, which is tremendous. If you look at the board of directors of MSK you will find that the drug industry has a dominant position on that board. One company in particular, Bristol Myers, which produces between 40 -50% of all the chemotherapy in the world, and they have top positions at MSK hospital.

Laura Lee: Doesn't that constitute a serious conflict of interest?

Dr.RALPH MOSS:
They are selling their own drugs to that particular hospital but they have written into the by-laws of the centre that it does not constitute a conflict of interest to sell their company drugs to the centre. They get around it by not taking a salary. They are not paid, they are volunteers. Look what happens. You have a man like Benno Schmidt, who was first head of the president's cancer
panel under Nixon, then becomes head of MSK. He then goes on using the knowledge he gained at MSK to set up his own drug company to make tens of millions of dollars.

Laura Lee:
Another revolving door.

Dr.RALPH MOSS:
You bet, and a big one. We have had 50 years of American Cancer Society (ACS) brainwashing on the question of cancer, so most people out there believe we are making progress in the war on cancer. We are not, we are losing the war. The statistics...

Laura Lee:
1.7% increase in terms of success rate a year, its nothing

Dr.RALPH MOSS:
By the time we get to the 24 century we might have effective treatments, Star Trek will be long gone by that time. It is not working, yet we have had this infrastructure, the cancer establishment imposed over this country for the last 50 years. It is a fund raising machine. The ACS takes in 400 million dollars a year. What are they doing with it? Where are the treatments? Where are the cures? Where is the good research? They are way way way out, far, drifting out to sea in terms of anything approaching human cancer. We have to re-orientate
ourselves around the actual patient in front of you. The only thing that matters in cancer or any other disease. Instead we have this very abstract, academic,
cruel, inhuman system which is now going to be forced down our throats by government decree.


Laura Lee:
I am told the tobacco industry tries to influence the boards of directors of some of these cancer hospitals.

Dr.RALPH MOSS:
At MSK in New York we had two top executives of Philip Morris and one of Nabisco on the board. You will not find much research being done on tobacco at MSK. They are not interested in tobacco, that is old hat, they are interested in P53 and other kind of weird genes that they find in their petri dishes. At the Tish hospital at NYU (New York University), named after the Tish family that is are
chairman of the board. They own the Laura Lard tobacco company, so they giveth and taketh away. They are going to give you cancer and then they will "cure" you of cancer, although they can't cure you. They will give you 3 months extra survival with vicious chemotherapy and call that a cure.

Laura Lee:
I'd rather die gracefully in my sleep.

Dr.RALPH MOSS:
You bet. You better not smoke and then most of the lung cancer wont happen, but that is one example of how the tobacco industry has infiltrated the medical establishment. The bigger thing is the industrial interests. If you look at the board of MSK you will find the who's who of the petro-chemical industry. Why are they there? Again, very little research is done on the effect of chemicals in
causing cancer. We know that is probably one of the main things that causes cancer---petro-chemical pollution. But that is denied denied. Of course it's denied, because the people who are paying the bill and directing cancer research have a vested interest in keeping the scientists away from that area, and keeping them focused on DRUG cures, things that can be patented, marketed and so
forth, and the FDA is in total collusion in this. They have set up a system where it costs hundreds of millions of dollars to develop a new drug in the US. Well, right there you know you are dealing with a monopoly situation.

Laura Lee:
You can't be a small company and afford those research bills.

Dr.RALPH MOSS:
You can't get in. It is a poker game where the ante is a 100 million dollars.

Laura Lee:
Don't we have anti-trust laws?


Dr.RALPH MOSS:
We are supposed to, and I have gone to people in the anti-trust division of the justice department. Their attitude is show us the smoking gun, in other words we want to see the conspiracy. Well I don't have access to the yachts off shore..

Laura Lee:
You can see it. You have big business looking at cancer as a potential growth industry.

Dr.RALPH MOSS:
You can come up with any results you want. You can buy the scientists to do that research. There are hired hands out there to attack any non-toxic treatment that you want to attack, and come up with some phoney results, give people synthetic vitamins with carcinogens, and that proves that vitamins cause cancer instead of curing cancer. You name it. If you have got the money you can buy the minority
of scientists who are corrupt, but they are out there. Basically most people know how the data on the breast cancer study at the National Cancer Institute was fudged. The question of wether lumpectomy was as good as mastectomy is now in somewhat doubt, because of the fake data that was submitted to the national surgical adjuvent and bowel project run out of the university of Pittsburg. This
kind of corruption and fakery, and abuse of the public has been going on as long as the war on cancer has been going on. The fact is that all of the studies that have been supervised by the National Cancer Institute should now be re-examined by congressional committees to see wether or not there is real corruption in all of them.

Laura Lee:
If there was an even playing field some of the alternative therapies would shine.

Dr.RALPH MOSS:
The Japanese are not afraid to look at things that are non-toxic. Here we will look at natural things as long as they are more toxic than chemotherapy. We don't want any competition. It would be unfair competition to have a less toxic drug than chemotherapy because everyone would then flock to the less toxic drug.

Laura Lee:
What is really sick is the industry leaders value their bottom line more than the well being and life of people.

Dr.RALPH MOSS:
Yes, because we have set up a situation where it costs hundreds of millions of dollars for a new drug. Once you have got a situation like that you have got to have a patent on the drug.

Laura Lee:
We know that natural substances cannot be patented.

Dr.RALPH MOSS:
If you want to change it you change the law that establishes the need for double blind clinical studies in drugs. You eliminate the efficacy clause from the Harris amendment to the food and drug act, which Harris himself didn't even want. This was imposed by the FDA and the drug industry. This upped the ante and made a regulatory barrier. Now instead of it taking 1 million dollars to
establish the safety of a drug, you now need 300 million dollars. So none of the small inventors, or the people with good ideas can ever hope to possibly hope to get their drugs approved. They put you in administrative limbo where the best you ever hope to get is this backburner simmering kind of thing, and I know of a number of good scientists who have got IND's (Investigative New Drug Applications) to test drugs, but when you try to market the drug they will put you out of business, and Dr Burzynski is the prime example. Brilliant scientist, wonderful results in cancer, validated by the NCI, and yet he is on the verge of
federal indictment.

Dr.RALPH MOSS:
If there is one thing you should pick up from this show tonight it's this: If you ever get into a situation where a doctor recommends chemotherapy to you or your family ask to see the studies that the chemotherapy actually extends the
life of the patient.

Laura Lee:
With chemo you may be shortening your life, certainly be under discomfort, certainly incurring huge costs. It can bankrupt you or your family. You have a right to know.

Dr.RALPH MOSS:
What are the actual toxicity? Go to a library to get a physicians desk reference, or my chemotherapy report. I am continuously amazed. I was doing some research due to my consultations on AML--a type of Leukemia, and the treatment
is so intense and toxic that in the older group that this particular patient fell into 40% die from the toxicity of the treatment.

Laura Lee:
40% would have lived longer if they hadn't had the treatment.

Dr.RALPH MOSS:
And the cure rate is miniscule, under 10%. It is terrible odds. In Las Vagas you wouldn't gamble with those odds unless you were crazy. The doctors fudge the statistics. They are confounding and confusing different issues, the response rate, the cure rate, the one year survival rate and so forth. Many doctors don't know any better. They are afraid. The widest prairies have electric fences and they are afraid to wander too close to the edge of their own field to find out what is on the other side because they know from the example of Dr Jonathen Wright or Burzynski that if you stray too far from the herd you are liable to
bump into one of those electric fences. So there is a kind of self censorship. I have seen this a hundred times. You talk to oncologists and doctors, and they are individually open-minded and interested but as an aggregate they will not move until their leadership moves because that is a very dangerous thing for an oncologist to do. They would stand out too much, and they can't afford to do that as they all depend on referrals from everyone else. So the minute you get branded as a "quack"----it is a conformist world, and in the professions the peer pressure is what makes for success or failure. Nobody wants to alienate
their peers, so you don't stick your neck out or you will get your head chopped off.

Laura Lee:
Lop the tallest poppy. Where does good science happen?
(Continues...)

RM:
Dr. Govallo in Russia who gets 75% five year survival in most carcinomas. Unbelievable. CG hormone. Trophoblastic cells. Cancer is similar to pregnancy. Cancer looks like a pregnancy. Dr Lance....isolate the blocking factor... analised proteins anti tumour necrosis factor....blocking factors of tumour.. we dismount immune system when pregnant... remove blocking proteins 3 patients with over 2 pounds of cancer...within 24 hours all dead on autopsy they
did not have a single cancer cells all gone in 48 hours.... but kidneys could not handle it.... they did not know about detox....the word detox does not appear in the main textbook on cancer or the main medical textbook...the word in medicine refers to heroin addicts and getting them off heroin....they do not conceive that their are such things as toxins created by a tumour...where do they think
it all goes?....it goes straight to the kidney, liver, lungs....Lentz learned to go slower... surgery can reduce tumour load...this failure is more exciting than most of the success I read about...it shows you how incredibly powerful the immune system is...it is not just that people have failing immune systems...it is primarily that the tumour can evade the immune system....it does not see the
tumour there...if you make it visible it will go in and wipe it out....the Burton Clinic in the Bahamas does this....Lentz did learn (1986) 2 patients who were terminal are still alive.... in 1902 a man, Beard, discovered cancer is trophoblast, wrong time wrong place............cancer is far too intelligent to submit to the raid approach of Allopathic medicine

Laura Lee:
Other research?

Dr.RALPH MOSS:
Burzynski, only available in Texas. Some results are amazing, for example in brain cancer. The NCI sent a team, finally, after we were asking them for 15 years, and validated the cases. I met one of the boys who was treated for a tumour about the size of pear in his brain. Within one month the tumour was gone, and it is 3 years down the road, cancer free. He has damage from the radiation treatment he recieved prior to that, he lost some of his hearing In non Hodgkinson lymphoma I have a friend who had stage 4, went through chemo, radiation and bone barrow stransplant. He failed the bone marrow transplantation. More chemotherapy. Read my book and found out about Dr
Burzynski, and its 5 years, and he is compleatly free of cancer... an amazing case.....he also took the whole "chicken soup" of vitamins etc.....why is this
better than chemo?...it is very low toxicity

Laura Lee:
You are talking about not damaged immune systems but how the immune system was fooled.

Dr.RALPH MOSS:
Exactly, but you still have to have an immune system. Chemo
decreases it..

Laura Lee:
And you are going to die when some other germ comes along.

Dr.RALPH MOSS:
Or another cancer comes along, which happens to about 10% of the people who survive the chemotherapy, they develop a second cancer, and they will never cure that one. It is almost impossible to cure. Another treatment COLEYS TOXINS which is one of the ones that excites me the most. This is not generally available though I do know of ways to get it in different forms. It was invented here like many of our alternative treatments and then they have to go abroad to be used. There is a Coley's hospital in China. They can get it in China but not here. It was discovered at MSK in 1893 and the results...over a 1000 people were treated with it. It is basically a high fever treatment. Some guy rung a radio show I was on, he had a sarcoma that was operated on, it spread, and his doctor sent him to Dr Coley. He was 13 at the time and 95 now. This is 82 years. Sarcoma is an incurable disease. A blow away treatment. In advanced terminal breast cancer they got compleat remissions in 50% of the cases using this treatment.

Laura Lee:
This is criminal.

Dr.RALPH MOSS:
That is not saying what you would get if you used it in conjunction with surgery, you may get a 100%

Laura Lee:
It is criminal that these are not incorporated into the standard procedures.

Dr.RALPH MOSS:
You bet, it is criminal. I have known about this and lived with it for 20 years.

You know what? THEY know about it at Sloane Kettering. They even put Coleys picture in their publicity material, as a pioneer of immunology, but they would never use the treatment themselves. They want to develop DRUGS that can be spun off like Tumour Necrosis Factor, like these other immunologically based drug treatments, highly toxic, destructive of the immune system, incredibly expensive.

Laura Lee:
It's big business.

Dr.RALPH MOSS:
Yes, he who pays the piper calls the tune, and the drug industry pays the piper.

Do you know what the MSK president makes?


Laura Lee:
$400,000?

Dr.RALPH MOSS:
That's chicken feed. The president of MSK makes 2 million dollars a year, 2.2 million.

Coleys toxins are bacteria that force the body to fever and kill them and the cancer as well. Tumours are very poorly vascularised, so you disrupt their ability to get nutrients and to get rid of wastes by raising the body temperature ..... this is really an effective treatment and it an OUTRAGEOUS crime of the century that we at MSK were able to cure cancer a 100 years ago that they can't cure today. This is a fraud being perpetrated on the public...

Laura Lee:
Why isn't the New York Times writing about this?

Dr.RALPH MOSS:
The chairman of the board of Bristol Myers, the main company producing anti-cancer drugs, who also happens to be on the board of MSK, is also on the board of the New York Times. Everybody's brother in law is an oncologist, or on
the board of somebody else's something or other, so it is a money making thing for the establishment. A hundred and seven billion, with a B, dollars a year business, and we are not going to get rid of it easily. The point is use your vote....

Laura Lee:
Or your mind

Dr.RALPH MOSS:
Or your mind, what a novel idea.

Laura Lee:
Lets work with it (cancer) rather than go out to stamp on it like a cockroach.

Dr.RALPH MOSS:
Chemotherapy is machismo practiced to the N'th degree. It is a war in which you are the battleground, lucky you, I mean you have to treat your body better than that. The folks that bring you the toxic chemicals that cause the cancer are then kind enough to bring you toxic chemicals that allegedly..... Laura Lee: We live in interesting times.

POR FAVOR FIRMA NUESTRO LIBRO DE VISITAS.

UNETE A NUESTRA COMUNIDAD DE AMIGOS.

TODA LA INFORMACION QUE APARECE EN ESTA PAGINA SE OFRECE A CUALQUIER PUBLICO DE MANERA TOTALMENTE GRATUITA,

RECONOCEMOS EL GRAN MERITO DEL TRABAJO Y ESFUERZO DE LOS AUTORES DEL MATERIAL QUE AQUÍ SE PUBLICA. SE RESPETAN TODOS LOS DERECHOS INTELECTUALES DE LOS AUTORES Y SUS TITULARES.